Nkarta Therapeutics has appointed Lisa Arjes as vice president of regulatory affairs and clinical quality. Ms. Arjes joins the company with 25 years of experience in engineering, quality, project management, drug supply and regulatory affairs in the biopharmaceutical industry. “As we advance our novel NK cell therapies toward the clinic, we are pleased to have Lisa leading our regulatory affairs and quality efforts, which are growing and expanding in the organization,” said Paul Hastings, pre...